关注
Marc Since
Marc Since
CERMN PRISMM plateforme, Univesité de Caen Normandie
在 unicaen.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
C Lecoutey, D Hedou, T Freret, P Giannoni, F Gaven, M Since, V Bouet, ...
Proceedings of the National Academy of Sciences 111 (36), E3825-E3830, 2014
1182014
Evaluation of the versatile character of a nanoemulsion formulation
E Gué, M Since, S Ropars, R Herbinet, L Le Pluart, A Malzert-Fréon
International Journal of Pharmaceutics 498 (1-2), 49-65, 2016
652016
Pharmacotechnical development of a nasal drug delivery composite nanosystem intended for Alzheimer’s disease treatment
T Adnet, AC Groo, C Picard, A Davis, S Corvaisier, M Since, F Bounoure, ...
Pharmaceutics 12 (3), 251, 2020
502020
Cyclic poly (α-peptoid) s by lithium bis (trimethylsilyl) amide (LiHMDS)-mediated ring-expansion polymerization: simple access to bioactive backbones
P Salas-Ambrosio, A Tronnet, M Since, S Bourgeade-Delmas, JL Stigliani, ...
Journal of the American Chemical Society 143 (10), 3697-3702, 2021
442021
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity
C Fersing, L Basmaciyan, C Boudot, J Pedron, S Hutter, A Cohen, ...
ACS Medicinal Chemistry Letters 10 (1), 34-39, 2018
422018
Inhibiting acetylcholinesterase to activate pleiotropic prodrugs with therapeutic interest in Alzheimer’s disease
FX Toublet, C Lecoutey, J Lalut, B Hatat, A Davis, M Since, S Corvaisier, ...
Molecules 24 (15), 2786, 2019
322019
Original TDAE strategy using α-halocarbonyl derivatives
M Since, T Terme, P Vanelle
Tetrahedron 65 (31), 6128-6134, 2009
312009
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer’s disease
FX Toublet, J Lalut, B Hatat, C Lecoutey, A Davis, M Since, S Corvaisier, ...
European Journal of Medicinal Chemistry 210, 113059, 2021
302021
Malzert Fréon
C Lecoutey, D Hedou, T Freret, P Giannoni, F Gaven, M Since, V Bouet, ...
A., Mignani, S., Cresteil, T., Boulouard, M., Claeysen, S., Rochais, C …, 2014
292014
Design, synthesis and biological evaluation of novel indano-and thiaindano-pyrazoles with potential interest for Alzheimer's disease
D Genest, C Rochais, C Lecoutey, J Sopkova-de Oliveira Santos, ...
MedChemComm 4 (6), 925-931, 2013
272013
Comparison of 2 strategies to enhance pyridoclax solubility: Nanoemulsion delivery system versus salt synthesis
AC Groo, M De Pascale, AS Voisin-Chiret, S Corvaisier, M Since, ...
European Journal of Pharmaceutical Sciences 97, 218-226, 2017
232017
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi
C Fersing, C Boudot, C Castera-Ducros, E Pinault, S Hutter, ...
European Journal of Medicinal Chemistry 202, 112558, 2020
202020
Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment
JP Jourdan, M Since, L El Kihel, C Lecoutey, S Corvaisier, R Legay, ...
European Journal of Medicinal Chemistry 114, 365-379, 2016
202016
Star-like poly (peptoid) s with selective antibacterial activity
P Salas-Ambrosio, A Tronnet, M Badreldin, L Reyes, M Since, ...
Polymer Chemistry 13 (5), 600-612, 2022
182022
Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer
AC Groo, S Hedir, M Since, E Brotin, LB Weiswald, H Paysant, G Nee, ...
International Journal of Pharmaceutics 587, 119655, 2020
172020
Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease
C Lanthier, H Payan, I Liparulo, B Hatat, C Lecoutey, M Since, A Davis, ...
European Journal of Medicinal Chemistry 182, 111596, 2019
152019
Benzylphenylpyrrolizinones with Anti‐amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment
JP Jourdan, M Since, L El Kihel, C Lecoutey, S Corvaisier, R Legay, ...
ChemMedChem 12 (12), 913-916, 2017
142017
A winning strategy to improve the anticancer properties of Cisplatin and Quercetin based on the nanoemulsions formulation
J Ceramella, AC Groo, D Iacopetta, L Séguy, A Mariconda, F Puoci, ...
Journal of Drug Delivery Science and Technology 66, 102907, 2021
132021
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic …
C Fersing, C Boudot, R Paoli-Lombardo, N Primas, E Pinault, S Hutter, ...
European Journal of Medicinal Chemistry 206, 112668, 2020
132020
New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi
J Pedron, C Boudot, JY Brossas, E Pinault, S Bourgeade-Delmas, ...
ACS Medicinal Chemistry Letters 11 (4), 464-472, 2020
132020
系统目前无法执行此操作,请稍后再试。
文章 1–20